Nestle has a newly-acquired company, and it is the protein shake maker, Orgain. The latter produces plant-based bars, shakes, and protein powders, and the Swiss multinational food and drink processing company headquartered in Vevey, Vaud, Switzerland, bought a majority stake for an undisclosed amount.
Andrew Abraham, Orgain's founder, and Butterfly Equity will remain shareholders of the company once the deal is completed. According to Food Dive, the agreement between Nestle and Orgain includes the option for the former to buy the rest of the shares in the company in 2024. Abraham will also retain his position as the chief executive officer of Orgain.
It was said that the stake acquisition will push and step up Nestlé's efforts to grow its health and wellness business unit. To attain its goal, the company will also be removing some of its divisions that are growing slowly compared to the others.
In fact, Nestlé already offloaded its confections and ice cream businesses and last year, it has also disposed of the majority of its North American bottled waters business for $4.3 billion as it was already struggling to stay afloat.
With its new deal with Orgain, Nestle will also be able to focus more on its other international premium brands that have big potential to grow further such as Perrier. Orgain will also give the firm fresh products to offer especially with the growing demand for plant-based items around the world. Furthermore, Orgain will give Nestle a deeper presence in trendy categories that are becoming really popular with consumers.
"Nutritional protein plays a key role in supporting our health and wellness, whether we enjoy an active lifestyle or are facing health challenges," Nestlé Health Science chief executive officer, Greg Behar, said in a press release. "Orgain's emphasis on clean, all natural, plant-based, organic ingredients has made it a leader in the U.S., and we look forward to combining our companies' expertise to bring Orgain to more people around the world."
Dr. Abraham, CEO and Founder of Orgain, also said, "We've worked hard to develop innovative products that make a real difference in consumers' lives, and now through Nestlé Health Science's capabilities, resources and dedication to nutrition, we will be able to reach more people around the world."
Meanwhile, the acquisition deal is still subject to customary regulatory approvals.


Nvidia Secures $500 Billion AI Infrastructure Push With Wall Street Giants
Gold Price Hits Two-Month High as Investors Await US Inflation Data
Australian Shares Fall as Westpac Slides, Miners Gain Ahead of RBA Decision
CBA Posts Record A$10.98B Profit Despite Cautious Outlook
Oil Prices Rise as Hormuz Reopening Remains Uncertain
Treasury Wine Estates Shares Jump as U.S. Overhaul Lifts FY2026 Outlook
Asian Stocks Mixed as RBA Holds Rates, Oil Risks Rise
Asian Currencies Steady as Markets Await U.S. Inflation Data
Goldman Sachs Sees US Stock Buybacks Outpacing Equity Issuance as AI Funding Rises
Asian Stocks Rise as Weak US Jobs Data Eases Fed Rate Hike Fears
England Drought Expands to 71% as Heatwave Deepens Water Crisis
Oil Prices Rise as Hormuz Reopening Remains Uncertain
Hanwha Offers Up to $1.2 Billion for Austal US Business
Delta Flight Makes Emergency Landing in Atlanta After Cockpit Fumes Reported
Gold Prices Hold Near Seven-Week High as Markets Await U.S. Inflation Data
Japan Posts First Current Account Deficit in 17 Months as Dividend Payments Surge
Shein Scales Back Vietnam Operations as US Trade Rules Shift 



